ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.

about

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.

Item

http://www.wikidata.org/entity/Q41058774

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.

@en

type

Item

label

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.

@en

prefLabel

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.

@en

P1476

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.

@en

P2093

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Gerald McMahon

http://www.w3.org/2001/XMLSchema#string

Gerald Wallweber

http://www.w3.org/2001/XMLSchema#string

Gwenda F Ligon

http://www.w3.org/2001/XMLSchema#string

Jay S Lillquist

http://www.w3.org/2001/XMLSchema#string

Scott B Seibel

http://www.w3.org/2001/XMLSchema#string

Theresa M LaVallee

http://www.w3.org/2001/XMLSchema#string

Veronique M Neumeister

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941

ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

Phosphotyrosine interactome of the ErbB-receptor kinase family

Targeting of erbB3 receptor to overcome resistance in cancer treatment

Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3

Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor

Comprehensive genomic characterization of head and neck squamous cell carcinomas

P304

e0181356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0181356

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Diego Alvarado

P577

2017-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28723928

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5517012

http://www.w3.org/2001/XMLSchema#string